Stocks
Funds
Screener
Sectors
Watchlists

Latest Almitas Capital LLC Stock Portfolio

Almitas Capital LLC Performance:
2024 Q3: 2.48%YTD: 1.62%2023: 0.02%

Performance for 2024 Q3 is 2.48%, and YTD is 1.62%, and 2023 is 0.02%.

About Almitas Capital LLC and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Almitas Capital LLC reported an equity portfolio of $283 Millions as of 30 Sep, 2024.

The top stock holdings of Almitas Capital LLC are , , . The fund has invested 21.9% of it's portfolio in FIDELITY WISE ORIGIN BITCOIN FUND and 8.4% of portfolio in BLACKROCK HEALTH SCIENCES TERM TRUST.

The fund managers got completely rid off NUVEEN PREFERRED & INCOME TERM FUND stocks. They significantly reduced their stock positions in ACELYRIN INC and GREAT AJAX CORP (AJX). Almitas Capital LLC opened new stock positions in FIDELITY WISE ORIGIN BITCOIN FUND, ZENTALIS PHARMACEUTICALS INC (ZNTL) and MIDCAP FINANCIAL INVESTMENT CORP (AIB). The fund showed a lot of confidence in some stocks as they added substantially to RALLYBIO CORP (RLYB), BLACKROCK MUNICIPAL 2030 TARGET TERM TRUST and ATEA PHARMACEUTICALS INC (AVIR).

Almitas Capital LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Almitas Capital LLC made a return of 2.48% in the last quarter. In trailing 12 months, it's portfolio return was 2.79%.

New Buys

Ticker$ Bought
fidelity wise origin bitcoin fund61,936,500
zentalis pharmaceuticals inc3,536,220
virtus total return fund inc1,908,300
tortoise power and energy infrastructure fund inc1,071,790
midcap financial investment corp963,451
first trust specialty finance and financial opportunities fund730,508
western asset inflation-linked opportunities & income fund558,096
vanguard s&p 500 etf511,840

New stocks bought by Almitas Capital LLC

Additions

Ticker% Inc.
rallybio corp767
blackrock municipal 2030 target term trust593
central and eastern europe fund inc227
tortoise energy independence fund inc184
western asset global corporate opportunity fund inc86.79
western asset investment grade opportunity trust inc61.87
bny mellon municipal income inc60.31
mfs high yield municipal trust54.4

Additions to existing portfolio by Almitas Capital LLC

Reductions

Ticker% Reduced
acelyrin inc-93.48
nuveen core plus impact fund-75.92
morgan stanley emerging markets domestic debt fund inc-74.03
blackrock california municipal income trust-73.09
taiwan fund inc/the/md-72.56
clough global dividend and income fund-65.05
eaton vance california municipal bond fund-64.41
blackrock esg capital allocation term trust-60.54

Almitas Capital LLC reduced stake in above stock

Sold off

Ticker$ Sold
bny mellon strategic municipal bond fund inc-3,322,820
nuveen preferred & income term fund-9,762,010
virtus convertible & income 2024 target term fund-2,449,140
invesco pennsylvania value municipal income trust-1,665,750
voya infrastructure industrials and materials fund-1,133,700
invesco trust for investment grade new york municipals-1,086,770
general american investors co inc-3,334,120
neuberger berman municipal fund inc-672,530

Almitas Capital LLC got rid off the above stocks

Sector Distribution

Almitas Capital LLC has about 90.3% of it's holdings in Others sector.

Sector%
Others90.3
Healthcare8.9

Market Cap. Distribution

Almitas Capital LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
UNALLOCATED90.3
MICRO-CAP9.1

Stocks belong to which Index?

About 8.7% of the stocks held by Almitas Capital LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others91.3
RUSSELL 20008.7
Top 5 Winners (%)%
AMLX
amylyx pharmaceuticals inc
69.5 %
DSGN
design therapeutics inc
57.1 %
NYMT
new york mortgage trust inc
8.4 %
QNCX
quince therapeutics inc
5.4 %
NKTR
nektar therapeutics
4.8 %
Top 5 Winners ($)$
AMLX
amylyx pharmaceuticals inc
2.6 M
DSGN
design therapeutics inc
2.6 M
NYMT
new york mortgage trust inc
0.1 M
ZNTL
zentalis pharmaceuticals inc
0.1 M
NKTR
nektar therapeutics
0.1 M
Top 5 Losers (%)%
SPRB
spruce biosciences inc
-8.3 %
ALLK
allakos inc
-7.1 %
AJX
great ajax corp
-5.8 %
HLVX
hillevax inc
-2.2 %
RLYB
rallybio corp
-0.2 %
Top 5 Losers ($)$
AJX
great ajax corp
-0.1 M
SPRB
spruce biosciences inc
0.0 M
HLVX
hillevax inc
0.0 M
ALLK
allakos inc
0.0 M
RLYB
rallybio corp
0.0 M

Almitas Capital LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Almitas Capital LLC

Almitas Capital LLC has 67 stocks in it's portfolio. About 60% of the portfolio is in top 10 stocks. AJX proved to be the most loss making stock for the portfolio. AMLX was the most profitable stock for Almitas Capital LLC last quarter.

Last Reported on: 14 Nov, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions